Queen, Adam Lambert to launch North America tour

SHARE Queen, Adam Lambert to launch North America tour
ap18337452587200_e1543846793153.jpg

Queen and Adam Lambert are launching a six-week North American tour following the release of the Freddie Mercury biopic “Bohemian Rhapsody.” | AP file photo

LOS ANGELES — Queen and Adam Lambert are launching a six-week North American tour after the release of the Freddie Mercury biopic “Bohemian Rhapsody.”

Live Nation announced the 23-date tour Monday. It will feature original band members Brian May and Roger Taylor with Adam Lambert singing lead. It will kick off in Vancouver, British Columbia, on July 10. It will end in Charlotte, North Carolina, on Aug. 23.

The tour stops in Chicago on Aug. 9 at the United Center. Other venues include Los Angeles, New York, Dallas and Atlanta.

Tickets for the “Rhapsody” tour will go on sale on Dec. 7.

Lambert says they have been “designing a brand new visual spectacle that will reframe these iconic songs and we are excited to unveil it!” He first shared the stage with Queen during the 2009 “American Idol” final.

The tour follows the group’s September run in Las Vegas.

The Latest
Girls says the man is angry that she stood up for her mom in a disagreement about the couple’s sex and drinking habits.
Parent company Global Tetrahedron has big plans to diversify the satire news website’s revenue streams and bring back a print edition
Trout Unlimited’s Trout In The Classroom teaches young students about fish and the aquatic environment, capped by a day trip to get all wet.
Businesses and neighborhood associations in River North and nearby want the city to end the dining program because of traffic congestion, delays to first responders and other headaches caused by closing off a major street artery, a local restaurant executive writes.
High doses become routine patient care even when they make patients so ill that they skip doses or stop taking the drugs. “There’s a gap in FDA’s authority that results in patients getting excess doses of a drug at excess costs,” says Dr. Mark Ratain, a University of Chicago oncologist.